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We have studied the impact of ionic liquid solvents on the
structure of the Abeta(1–40) peptide from Alzheimer’s disease
and found that ionic liquid solvents were able to induce a
conformational change in the structure of the Abeta(1–40)
peptide. This conformational change impacts the self-assembly
of the peptide into amyloid fibrils.
Protein folding is a research topic that generates intense
research efforts worldwide.1–3 The importance of understanding
protein misfolding4 has direct implications in understanding
the origins of human disease that stem from protein misfolding.
These diseases include Alzheimer’s disease, Parkinson disease,
and type II diabetes. Insight into the mechanisms by which
proteins fold has led to significant advances in the development
of treatments for these diseases of protein misfolding. The
ability to manipulate a protein’s secondary structure and study
the interactions responsible for conformational change is at
the core of protein folding research. To this end, additives that
can denature proteins such as urea and GndHCI have been
extensively used to study the various interactions occurring
during protein unfolding.5–7 In addition to additives that
denature proteins, additives that stabilize the secondary
structure have been central to studying the interactions that
promote the secondary structure. A commonly used structure
inducing solvent is trifluoroethanol (TFE).8,9 TFE is known to
induce an a helical structure in a wide range of proteins and
peptides,9 and so TFE has been extensively employed in
protein folding studies. Other solvents including the cationic
surfactant, sodium dodecyl sulfate (SDS),10 and metal ions11
have been reported to perturb the secondary structure of the
Abeta(1–40) peptide altering the kinetics of fibril formation.
SDS is routinely used to study protein interactions as its
surfactant nature resembles a membrane.
In this communication we demonstrate the structure
inducing capabilities of triethylammonium methanesulfonate,12
TeaMs, a protic ionic liquid. Ionic liquids present as design
solvents capable of being tailored to meet the requirements of
a vast range of applications and so have attracted enormous
research interest across a broad spectrum of fields. Ionic
liquids as solvents for biomolecules have attracted increasing
attention due largely to the beneficial outcomes that result
from their use, including increased thermal stability13 and
shelf life14 of proteins and DNA, enhanced refolding of
proteins,15,16 increased biocatalytic reactions17 and as additives
for protein crystallization.18 Ionic liquids have recently been
shown to inhibit, or at least alter, the kinetics in the growth of
an amyloid oligomer species of Hen egg white lysozyme,
HEWL.19 In this study various ionic liquids were tested with
varying degrees of success. The authors speculated that the
successful ionic liquid was selectively interacting with some of
the oligomeric species via cation–p interactions, due to the
high amount of aromatic amino acids present in the HEWL
sequence, due to the presence of 6 Trp residues. Although no
clear structure change was observed in this study, it did show
that interactions with the beta oligomers of HEWL is an ionic
liquid property and not the consequence of solvated ions. As
such, the use of ionic liquids to alter the fibrilization process
and to stabilize different amyloidal species opens up a new
realm of possibilities in probing protein conformational states
and exploring new protein–solvent interactions that warrant
more attention.
In our laboratory we are interested in protic ionic liquids
(pILs). PILs are a sub-class of the ionic liquid family formed
by the neutralization of a Bronsted base with a Bronsted acid.
For complete transfer to occur and ensure that the resultant
pIL is not a mixture of salt, acid and base a DpKa 4 10 is
required.12 PILs have an additional tuneable feature that
results due to this proton transfer, the proton activity. The
proton activity has been used as a relative scale to select
appropriate pILs for the solvation of biomolecules20 and in
the support of various organic reactions.21
In this study we have investigated the influence of increasing
the concentration of the ionic liquid TeaMs on the secondary
structure and the formation of amyloid fibrils of the Abeta(1–40)
peptide. We have selected this peptide due to its role in the
pathogenesis of Alzheimer’s disease and as it is a well studied
model for amyloid formation. We have selected this pIL as it
was shown to stabilize HEWL.14 We have used circular
dichroism to systematically measure changes in the secondary
structure and transmission electron microscopy was used
to observe the morphology of the fibrils. The Abeta(1–40)
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peptide was synthesised using manual solid-phase Boc
chemistry.22
Fig. 1 shows the far CD spectrum for the Abeta(1–40) in
aqueous solutions containing TeaMs concentration between
70 wt% and 80 wt%. A clear alpha helix structure is adopted
by the Abeta peptide at these high TeaMs loadings. The ability
to induce an alpha helix structure in the Abeta peptide has
been previously reported with additions of 60 vol% TFE.
While the exact mechanism of how TFE induces a structure is
still debatable it is generally accepted that the nonpolar to
polar balance of TFE results in disruption of the intramolecular
hydrogen bonds which are essential for beta sheet formation,
while also promoting the hydrogen bonding occurring in
monomeric alpha-helical species. A likely mechanism for the
helical stabilization effects of TFE is that TFE molecules
aggregate around the peptide, displacing water and thus
removing alternative hydrogen-bonding partners and providing
a low dielectric environment that favors the formation of
intrapeptide hydrogen bonds.23
At low concentrations in aqueous buffer TFE is known to
accelerate amyloid fibril formation. To see if TeaMs had a
similar response we studied the influence lower concentrations
of TeaMs had on the structure and the fibril formation of
Abeta(1–40). Fig. 2a shows the far CD spectrum for TeaMs
concentrations 60 wt% and below, at all concentrations below
50 wt% TeaMs adopts a classic beta sheet secondary structure.
At 60 wt% TeaMs concentration a minimum around 209 nm
is observed, this suggests that some a helix structure is present.
We examined the solutions using transmission electron micro-
scopy (TEM). Fig. 2b and c shows the TEM images for the
Abeta(1–40) peptide dissolved in the presence of 10 wt%
TeaMs and 50 wt% TeaMs after incubation for 1 week.
The presence of long flexible fibrils can be seen in both
micrographs, supporting the Beta sheet secondary structure
measured from CD. In addition these solutions both showed
positive fluorescence intensity when tested with the amyloid
sensitive dye thioflavin T, Tht.
We also examined the solutions with TeaMs concentrations
responsible for inducing an alpha helix structure, 70 wt%,
75 wt%, 78 wt% and 80 wt%, and no fibrils were found in any
of these solutions after a period of up to six weeks. At TeaMs
concentrations of 90 wt% and above the Abeta(1–40) peptide
lacks any structure (ESIw, Fig. S1). The CD spectrum at this
high TeaMs concentration is representative of an unstructured
peptide. Solutions containing 90 wt% and 100 wt% TeaMs
were also examined using TEM for the presence of fibrils, and
no fibrils were found in these solutions. To ensure the absence
of fibrils in these solutions we measured the fluorescence
response of ThT, and no intensity was measured, indicating
the absence of beta sheet. The inability for Abeta(1–40) to
adopt any structure in TeaMs solutions of 90 wt% and
100 wt% is an interesting outcome and suggests that the
electrostatic screening abilities of TeaMs prevent the formation
of sufficient intramolecular or intermolecular hydrogen bonds
required for folding.
We also investigated the influence of TeaMs on a modified
amyloid b peptide based on the Abeta(16–22) fragment,
KLVFF. This fragment has been identified as a key sequence
involved in b sheet fibril formation of the full length Abeta
peptide. Fig. 3 highlights the structure inducing abilities of
TeaMs. The far CD spectrum is measured at a constant
peptide concentration of 100 mM. The concentration of TeaMs
is varied. An increase in the alpha helicity of the peptide is
observed at increasing TeaMs concentrations. The changes
induced by varying the concentration of TeaMs are not a
Fig. 1 Far CD spectrum of Abeta(1–40) in aqueous pIL solution, at
TeaMs concentrations of 70 wt% (black), 75 wt% (green), 78 wt%
(blue) and 80 wt% (red).
Fig. 2 (a) Far CD spectrum of Abeta(1–40) as a function of low
TeaMs concentration, 10 wt% to 60 wt% at 10 wt% increments,
arrows indicate increasing TeaMs concentration, (b) TEMmicrograph
of Abeta(1–40) in aqueous pIL solution containing 10 wt% TeaMs
and (c) TEM micrograph of Abeta(1–40) in aqueous pIL solution
containing 50 wt% TeaMs. Scale bar 200 nm.
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result of changing the pH of the solution, which is known to
alter the secondary structure of peptides. To confirm this, we
measured the secondary structure of the peptide from pH 2 to
pH 9, shown in Fig. 3b. No change in the secondary structure
of the modified b peptide was observed across this wide pH
range in aqueous buffer conditions, suggesting that pH is not
driving the structure changes.
The spectrum obtained for the modified Ab peptide in
TeaMs is considerably more intense (higher molar elipticity)
when compared to the same peptide measured in the aqueous
solutions of different pH values. The increased intensity may
be the result of either increased chiral ordering as the peptide
adopts an alpha helix structure, or enhanced solubility as a
result of the ionic liquid. Ionic liquids have previously been
shown to increase the solubility of difficult to solubilise
molecules due to the electrostatic nature of the ionic liquid.
The ability for TeaMs to induce an alpha helix structure
does not seem to be limited to TeaMs alone, with initial studies
showing other similarly structured ionic liquids such as
ethylammoniummesylate (EaMs), propylammoniummesylate
(PropMs), ethylammonium nitrate (EaN) and triethylammonium
trifluoromethanesulfonate (TeaTf), all have the ability to
induce a helical structure in the above beta peptide (ESIw
data, Fig. S2). The mechanism by which these protic ionic
liquids can alter the hydrogen bonding nature of the peptide
such that intermolecular bonds are favoured over the beta
sheet forming intramolecular bonds may be the result of the
unique hydrogen bonded network system of the protic ionic
liquid. Alternatively, given that solvents, which create a
‘‘membrane like’’ environment such as TFE, Hexafluoroiso-
propanol, HFIP, and SDS, have all been shown to induce a
helical structure in Abeta peptides, it is plausible that the
presence of aggregated species within the ionic liquid could be
creating a bilayer effect. Indeed, studies of ionic liquid:
aqueous solutions show that aggregated species exist and
studies investigating ‘poorly ionic’ liquids which describe many
protic ionic liquids have found the presence of aggregates24
which maybe contributing to their solvent structuring properties.
Further studies investigating the role of the ionic liquids in the
fibril formation and the stabilization of amyloid species in beta
peptides are currently underway, with particular focus on the
use of ionic liquids as beta sheet blockers.
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